Nanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction.
Ingrid Marie HeynsAlina Farah FaunceMercy Ngosa MumbaNaga Venkata Ravi Kumar MajetiMeenakshi AroraPublished in: ACS pharmacology & translational science (2024)
Opioids are commonly prescribed to address intense, ongoing pain associated with cancer, as well as long-lasting noncancer-related pain when alternative methods have proven ineffective. Individuals who exhibit both chronic pain and misuse of opioids face a significant danger of experiencing adverse health outcomes and the potential loss of life related to opioid use. Thus, there is a current movement to prescribe naloxone to those considered high-risk for opioid overdose. Naloxone has been explored as an antidote to reverse acute respiratory depression. Conversely, naloxone can give rise to other problems, including hypertension and cardiac arrhythmias. Thus, the importance of nanotechnology-enabled drug delivery strategies and their role in mitigating naloxone side-effects are significant. In this review, we explore the latest advancements in nanotechnology-enabled naloxone and alternative methods for addressing the opioid crisis through the utilization of non-opioid natural alternatives for chronic pain management.
Keyphrases
- chronic pain
- pain management
- drug delivery
- public health
- blood pressure
- liver failure
- mental health
- papillary thyroid
- depressive symptoms
- left ventricular
- heart failure
- sleep quality
- extracorporeal membrane oxygenation
- physical activity
- cancer therapy
- climate change
- intensive care unit
- hepatitis b virus
- atrial fibrillation
- lymph node metastasis
- acute respiratory distress syndrome